Nuzenio

Allsci China

Allsci China entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

country 21 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 16:31:47 GMTChina accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSci
Fri, 07 Aug 2026 16:28:01 GMTBioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSci
Fri, 07 Aug 2026 16:21:02 GMTSino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSci
Fri, 07 Aug 2026 14:00:52 GMTEdding Genor tries trispecific PD-1/CTLA-4/VEGF antibody against breast cancer - AllSci
Fri, 07 Aug 2026 13:52:15 GMTBiogen closes deal for USD 1b buyout of RayThera - AllSci
Fri, 07 Aug 2026 13:40:45 GMTEU clears label expansion for Bavarian Nordic's Mpox vaccine to children as young as two - AllSci

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Allsci China.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.